Thyrocare Technologies Limited (NSE:THYROCARE)
584.00
+18.45 (3.26%)
Aug 24, 2026, 3:30 PM IST
Thyrocare Technologies Market Cap
Thyrocare Technologies has a market cap or net worth of 92.98 billion as of August 24, 2026. Its market cap has increased by 38.99% in one year.
Market Cap
92.98B
Enterprise Value
91.60B
Revenue
8.76B
Ranking
n/a
PE Ratio
52.74
Stock Price
584.00
ChartMarket Cap Chart
Since May 9, 2016, Thyrocare Technologies's market cap has increased from 33.20B to 92.98B, an increase of 180.06%. That is a compound annual growth rate of 10.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 92.98B | 30.99% |
| Dec 31, 2025 | 70.99B | 46.48% |
| Dec 31, 2024 | 48.46B | 42.22% |
| Dec 29, 2023 | 34.08B | 4.19% |
| Dec 30, 2022 | 32.71B | -44.08% |
| Dec 31, 2021 | 58.49B | 21.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.56T |
| Divi's Laboratories | 2.28T |
| Apollo Hospitals Enterprise | 1.25T |
| Cipla | 1.16T |
| HealthCare Global Enterprises | 108.39B |
| Jupiter Life Line Hospitals | 101.55B |
| Sanofi Consumer Healthcare India | 97.24B |
| Strides Pharma Science | 90.90B |